Tacrolimus and nonsteroidal anti-inflammatory drugs:: An association to be avoided

被引:16
作者
Soubhia, RMC
Mendes, GEF
Mendonça, FZ
Baptista, MAS
Cipullo, JP
Burdmann, EA
机构
[1] Sao Jose do Rio Preto Med Sch, Div Nephrol, Sao Paulo, Brazil
[2] Sao Jose do Rio Preto Med Sch, Div Internal Med, Sao Paulo, Brazil
关键词
acute nephrotoxicity; acute renal failure; nonsteroidal anti-inflammatory drugs; tacrolimus; diclofenac; rofecoxib; COX-1; COX-2; selective cyclooxygenase inhibitors;
D O I
10.1159/000086569
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Tacrolimus (FK) and nonsteroidal anti-inflammatory drugs (NSAIDs) can cause acute nephrotoxicity. The expanding use of tacrolimus and the intense consumption of NSAIDS increase the chances of their simultaneous use. Methods: Rats receiving a nonselective COX inhibitor (diclofenac, D) and FK or a selective COX-2 inhibitor (rofecoxib, RO) and FK were treated with FK (2 mg/kg/day), D (10 mg/kg/day), RO (3 mg/kg/day), FK+D, FK+RO and vehicle for 7 days on low-salt diet. Results: Both associations significantly impaired glomerular filtration rate (GFR; 0.63 +/- 0.06 ml/min/100 g in FK+D, 0.83 +/- 0.06 ml/min/100 g in FK+RO) which did not occur with single drug therapy (0.98 +/- 0.03 ml/min/100 g in D, 1.06 +/- 0.04 ml/min/100 g in RO, 0.99 +/- 0.05 ml/min/ 100 g in FK) or vehicle (1.10 +/- 0.05 ml/min/100 g). GFR decrease was significantly higher with FK+D. GFR impairment occurred without RBF or RVR major changes. Mild tubular vacuolization and dilatation and acute degenerative changes were observed in tubular cells. FK+D animals showed a marked weight loss, not observed in the other groups. FK+NSAIDs association decreased FK blood levels (1.73 +/- 0.3 ng/ml in FK+D, 1.8 +/- 0.3 ng/ml in FK+RO, 3.2 +/- 0.4 ng/ml in FK, p < 0.05). Conclusions: The association of FK and nonselective or COX-2 selective NSAIDs in salt-depleted animals caused a significant GFR impairment and decreased FK blood levels. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:327 / 334
页数:8
相关论文
共 38 条
[11]   Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes [J].
Christians, U ;
Schmidt, G ;
Bader, A ;
Lampen, A ;
Schottmann, R ;
Linck, A ;
Sewing, KF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (03) :187-190
[12]   Pharmacology of immunosuppressive medications used in renal diseases and transplantation [J].
deMattos, AM ;
Olyaei, AJ ;
Bennett, WM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) :631-667
[13]  
DERAY G, 1987, CLIN NEPHROL, V27, P213
[14]   Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors [J].
Gambaro, G ;
Perazella, MA .
JOURNAL OF INTERNAL MEDICINE, 2003, 253 (06) :643-652
[15]   FK-506 - EFFECTS ON GLOMERULAR HEMODYNAMICS AND ON MESANGIAL CELLS IN CULTURE [J].
HADAD, SJ ;
SOUZA, ERM ;
FERREIRA, AT ;
OSHIRO, MEM ;
BOIM, MA ;
RAZVICKAS, CV ;
MOURA, LAR ;
SCHOR, N .
KIDNEY INTERNATIONAL, 1995, 48 (01) :56-64
[16]  
Harris RC, 2000, J AM SOC NEPHROL, V11, P2387, DOI 10.1681/ASN.V11122387
[17]   UROLINK: a model for working together in a changing world [J].
Harrison, NW .
BJU INTERNATIONAL, 2002, 89 :1-5
[18]   The cyclooxygenase-2 inhibitors: Safety and effectiveness [J].
Kaplan-Machlis, B ;
Klostermeyer, BS .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (09) :979-988
[19]   Interspecies differences in renal localization of cyclooxygenase isoforms: Implications in nonsteroidal antiinflammatory drug-related nephrotoxicity [J].
Khan, KNM ;
Venturini, CM ;
Bunch, RT ;
Brassard, JA ;
Koki, AT ;
Morris, DL ;
Trump, BF ;
Maziasz, TJ ;
Alden, CL .
TOXICOLOGIC PATHOLOGY, 1998, 26 (05) :612-620
[20]  
Kondo H, 2004, J RHEUMATOL, V31, P243